bioRxivBioinformaticsPreprint
The systematic assessment of completeness of public metadata accompanying omics studies in the Gene Expression Omnibus
Yu-Ning HuangiD, Pooja Vinod JaiswaliD, Anushka RajeshiD, Anushka YadaviD, Dottie YuiD, Fangyun LiuiD, Grace Scheg, Emma Shih, Grigore BoldireviD, Irina NakashidzeiD, Aditya Prasad SarkariD, Jay Himanshu Mehta, Ke WangiD, Khooshbu Kantibhai PateliD, Mustafa Ali Baig Mirza, Kunali Chetan HapaniiD, Qiushi PengiD, Ram AyyalaiD, Ruiwei GuoiD, Shaunak KapuriD, Tejasvene RameshiD, Dumitru CiorbăiD, Viorel MunteanuiD, Viorel BostaniD, Mihai DimianiD, , Serghei ManguliD
Abstract
Recent advances in high-throughput sequencing technologies have made it possible to collect and share a massive amount of omics data, along with its associated metadata. Enhancing metadata availability is critical to ensure data reusability and reproducibility and to facilitate novel biomedical discoveries through effective data reuse. Yet, incomplete metadata accompanying public omics data may hinder reproducibility and reusability by reducing sample interpretability and limiting secondary analyses. In this study, we performed a comprehensive assessment of metadata completeness shared in both scientific publications and/or public repositories by analyzing over 253 studies encompassing over 164 thousands samples, including both human and non-human mammalian studies. We observed that studies often omit over a quarter of important phenotypes, with an average of only 74.8% of them shared either in the text of publication or the corresponding repository. Notably, public repositories alone contained 62% of the metadata, surpassing the textual content of publications by 3.5%. Only 11.5% of studies completely shared all phenotypes, while 37.9% shared less than 40% of the phenotypes. Studies involving non-human samples were more likely to share metadata than studies involving human samples. We observed similar results on the extended dataset spanning 2.1 million samples across over 61,000 studies from the Gene Expression Omnibus repository. The limited availability of metadata reported in our study emphasizes the necessity for improved metadata sharing practices and standardized reporting. Finally, we discuss the numerous benefits of improving the availability and quality of metadata to the scientific community and beyond, supporting data-driven decision-making and policy development in the field of biomedical research. This work provides a scalable framework for evaluating metadata availability and may help guide future policy and infrastructure development.
- organism: human
- organism: non-human primate
- assay: bulk RNA-seq
- research focus: benchmarking
- research focus: database / resource
- approach: statistical model
- Citations
- 4
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Large-scale Manual Curation and Harmonization of Metadata from Metagenomic and Cancer Genomic Repositories: Challenges and Solutions
Kaelyn Long, Kai Gravel-Pucillo, … Sehyun Oh·DatabasePeer-reviewed·Jan 1, 2026
- Obstacles to the Reuse of Study Metadata in ClinicalTrials.gov
L. Miron, R. S. Goncalves, M. Musen·bioRxiv·Nov 11, 2020
- Omics Discovery Index - Discovering and Linking Public Omics Datasets
Yasset Perez-Riverol, Mingze Bai, … Henning Hermjakob·bioRxiv·Apr 18, 2016
- Maximizing the Reusability of Gene Expression Data by Predicting Missing Metadata
Pei-Yau Lung, Dongrui Zhong, … Jinfeng Zhang·PLoS Computational BiologyPeer-reviewed·Nov 6, 2020
- Revealing the Hidden Landscape of Public Metabolomics Data Reuse in MetaboLights
Ibrahim Karaman, Thomas Payne, Juan Antonio Vizcaíno·bioRxiv·May 5, 2026
- Who Funds Open Data Sharing? Analysis of data availability statements in biomedical publications
Josh Lawrimore, Congxiang Li, … Adam G Thomas·bioRxiv·Jul 20, 2026